Werfen, a Barcelona, Spain-based family-owned, specialized diagnostics company, announced the launch of We Venture Capital, its corporate venture capital arm.
We Venture Capital focuses on investing in diagnostics startups, as well as digital solutions and biotechnology, surrounding the diagnostics space globally.
With an evergreen structure, the arm invests primarily in Series A, and may also invest in Seed or Series B. With an early-stage focus, investments target startups close to market, or early market entrants ready to scale up. We Venture Capital actively partners with its portfolio companies and supports their growth by leveraging its knowledge of specialized diagnostics worldwide.
Commenting on the launch, Louise Warme, Head of We Venture Capital, said: “Our investment team is truly passionate about partnering with start-ups that drive change and technological disruption in the diagnostics field, and we aim to become a leader in diagnostic venture capital. We want to thank everyone who has supported this launch and for bringing We Venture Capital to life.”
We Venture Capital currently holds 2 portfolio companies in portfolio including:
- Axithra, a spin-off from Ghent University and imec, advancing a platform to measure and monitor drug concentrations in blood, paving the way for treatments tailored to the specific needs of each individual, at any given time, and
- deepul, a biotechnology company developing an early diagnosis of sepsis and therapeutic recommendations.
Founded in 1966, Werfen is a worldwide leader in specialized diagnostics in the areas of Hemostasis, Acute Care Diagnostics, Autoimmunity, and Transfusion and Transplant. Through its Original Equipment Manufacturing (OEM) business line, the company researches, develops and manufactures customized assays and biomaterials. They operate directly in 30 countries, and in more than 100 territories through distributors. Its headquarter is in Barcelona, Spain, with Technology Centers located in the US and Europe. Worldwide sales exceed US$2.2 billion annually, and the workforce is more than 7,000 strong.